PHE - Corporate - Supporting Prospective AI trials in Breast Screening

Artificial Intelligence (AI) companies are starting to be granted funding by the Accelerated Access Collaborative (AAC) for evaluating their AI products in the NHS Breast Cancer Screening Programme (NHS BSP). Public Health England (PHE) are keen to support these studies in a way that benefits the programme and minimises the risk for operational services and IT systems. For this reason, PHE are arranging an engagement day with AI companies known to the programme to understand what the likely demands on the NHS BSP I...